Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.63
CERN's Cash-to-Debt is ranked lower than
78% of the 1687 Companies
in the Global Health Information Services industry.

( Industry Median: 10.14 vs. CERN: 0.63 )
Ranked among companies with meaningful Cash-to-Debt only.
CERN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.63  Med: 1.47 Max: 10.9
Current: 0.63
0.63
10.9
Equity-to-Asset 0.70
CERN's Equity-to-Asset is ranked higher than
67% of the 1591 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. CERN: 0.70 )
Ranked among companies with meaningful Equity-to-Asset only.
CERN' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.55  Med: 0.68 Max: 0.79
Current: 0.7
0.55
0.79
Interest Coverage N/A
CERN's Interest Coverage is ranked higher than
70% of the 1515 Companies
in the Global Health Information Services industry.

( Industry Median: 177.64 vs. CERN: N/A )
Ranked among companies with meaningful Interest Coverage only.
CERN' s Interest Coverage Range Over the Past 10 Years
Min: 17.1  Med: 76.09 Max: N/A
Current: N/A
Piotroski F-Score: 6
Altman Z-Score: 9.29
Beneish M-Score: -2.99
WACC vs ROIC
9.18%
15.57%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 18.99
CERN's Operating Margin % is ranked higher than
85% of the 1627 Companies
in the Global Health Information Services industry.

( Industry Median: 4.30 vs. CERN: 18.99 )
Ranked among companies with meaningful Operating Margin % only.
CERN' s Operating Margin % Range Over the Past 10 Years
Min: 13.43  Med: 19.21 Max: 22.43
Current: 18.99
13.43
22.43
Net Margin % 13.27
CERN's Net Margin % is ranked higher than
82% of the 1628 Companies
in the Global Health Information Services industry.

( Industry Median: 2.79 vs. CERN: 13.27 )
Ranked among companies with meaningful Net Margin % only.
CERN' s Net Margin % Range Over the Past 10 Years
Min: 8.36  Med: 13.05 Max: 15.44
Current: 13.27
8.36
15.44
ROE % 15.88
CERN's ROE % is ranked higher than
76% of the 1573 Companies
in the Global Health Information Services industry.

( Industry Median: 5.51 vs. CERN: 15.88 )
Ranked among companies with meaningful ROE % only.
CERN' s ROE % Range Over the Past 10 Years
Min: 12.37  Med: 14.53 Max: 16.32
Current: 15.88
12.37
16.32
ROA % 11.16
CERN's ROA % is ranked higher than
84% of the 1692 Companies
in the Global Health Information Services industry.

( Industry Median: 2.52 vs. CERN: 11.16 )
Ranked among companies with meaningful ROA % only.
CERN' s ROA % Range Over the Past 10 Years
Min: 7.98  Med: 10.63 Max: 12.18
Current: 11.16
7.98
12.18
ROC (Joel Greenblatt) % 47.59
CERN's ROC (Joel Greenblatt) % is ranked higher than
63% of the 1648 Companies
in the Global Health Information Services industry.

( Industry Median: 21.15 vs. CERN: 47.59 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CERN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 36.87  Med: 48.76 Max: 73.16
Current: 47.59
36.87
73.16
3-Year Revenue Growth Rate 19.10
CERN's 3-Year Revenue Growth Rate is ranked higher than
83% of the 1425 Companies
in the Global Health Information Services industry.

( Industry Median: 5.20 vs. CERN: 19.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CERN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 5.8  Med: 15 Max: 29.6
Current: 19.1
5.8
29.6
3-Year EBITDA Growth Rate 20.30
CERN's 3-Year EBITDA Growth Rate is ranked higher than
71% of the 1193 Companies
in the Global Health Information Services industry.

( Industry Median: 7.70 vs. CERN: 20.30 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CERN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -11.9  Med: 16.6 Max: 71.1
Current: 20.3
-11.9
71.1
3-Year EPS without NRI Growth Rate 17.90
CERN's 3-Year EPS without NRI Growth Rate is ranked higher than
65% of the 1077 Companies
in the Global Health Information Services industry.

( Industry Median: 7.70 vs. CERN: 17.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CERN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -26.3  Med: 19.9 Max: 448.5
Current: 17.9
-26.3
448.5
GuruFocus has detected 2 Warning Signs with Cerner Corp $CERN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CERN's 10-Y Financials

Financials (Next Earnings Date: 2017-05-09 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

CERN Guru Trades in Q1 2016

Steven Cohen 16,100 sh (New)
Jim Simons 817,604 sh (+894.18%)
Paul Tudor Jones 26,880 sh (+673.30%)
Ray Dalio 83,332 sh (+162.69%)
Manning & Napier Advisors, Inc 6,935,162 sh (+45.89%)
Murray Stahl 11,167 sh (+13.24%)
Vanguard Health Care Fund 16,949,730 sh (+3.20%)
PRIMECAP Management 20,000 sh (unchged)
Jeremy Grantham Sold Out
Louis Moore Bacon Sold Out
Ron Baron Sold Out
Frank Sands 12,217,479 sh (-9.38%)
» More
Q2 2016

CERN Guru Trades in Q2 2016

Joel Greenblatt 19,163 sh (New)
George Soros 10,800 sh (New)
Manning & Napier Advisors, Inc 8,496,202 sh (+22.51%)
Vanguard Health Care Fund 16,949,730 sh (unchged)
PRIMECAP Management 20,000 sh (unchged)
Jim Simons Sold Out
Steven Cohen Sold Out
Frank Sands 11,518,519 sh (-5.72%)
Murray Stahl 9,479 sh (-15.12%)
Paul Tudor Jones 21,608 sh (-19.61%)
Ray Dalio 54,000 sh (-35.20%)
» More
Q3 2016

CERN Guru Trades in Q3 2016

Jim Simons 748,404 sh (New)
Jeremy Grantham 1,285,818 sh (New)
Paul Tudor Jones 31,283 sh (+44.78%)
PRIMECAP Management 20,000 sh (unchged)
George Soros Sold Out
Vanguard Health Care Fund 16,772,630 sh (-1.04%)
Manning & Napier Advisors, Inc 8,197,607 sh (-3.51%)
Frank Sands 10,775,077 sh (-6.45%)
Murray Stahl 8,177 sh (-13.74%)
Ray Dalio 31,900 sh (-40.93%)
Joel Greenblatt 10,926 sh (-42.98%)
» More
Q4 2016

CERN Guru Trades in Q4 2016

Jeff Auxier 35,975 sh (New)
Arnold Van Den Berg 333,386 sh (New)
Third Avenue Management 408,707 sh (New)
Joel Greenblatt 166,304 sh (+1422.09%)
Ray Dalio 249,175 sh (+681.11%)
Jim Simons 1,252,504 sh (+67.36%)
Murray Stahl 10,397 sh (+27.15%)
Vanguard Health Care Fund 16,918,530 sh (+0.87%)
Jeremy Grantham 1,291,903 sh (+0.47%)
PRIMECAP Management 20,000 sh (unchged)
Manning & Napier Advisors, Inc 3,870,904 sh (-52.78%)
Paul Tudor Jones 12,246 sh (-60.85%)
Frank Sands 3,123,675 sh (-71.01%)
» More
» Details

Insider Trades

Latest Guru Trades with CERN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Health Information Services    NAICS: 519190    SIC: 8099
Compare:NYSE:VEEV, NAS:ATHN, NAS:MDSO, NAS:HQY, OTCPK:CMPVF, NAS:WBMD, NAS:INOV, NAS:PINC, NAS:OMCL, NYSE:EVH, NYSE:TDOC, NAS:QSII, NAS:HSTM, NAS:NH, NAS:CPSI, NAS:RCM, NAS:TRHC, OTCPK:SNBP, OTCPK:COGZF, OTCPK:CNAB » details
Traded in other countries:CRE.Germany, CERN.Switzerland, 0R00.UK,
Cerner Corp is a supplier of health care information technology, and offers software, professional services, medical device integration, remote hosting and employer health and wellness services.

Cerner is a top-tier healthcare information technology supplier that helps to eliminate errors and improve efficiency within complex healthcare organizations. The company provides a wide range of software, hardware, and services to more than 9,000 facilities globally and has a footprint in roughly 30% of all U.S. hospitals.

Guru Investment Theses on Cerner Corp

Third Avenue Management Comments on Cerner - Feb 01, 2017

Cerner (NASDAQ:CERN) is a leading health care information technology company. We have long admired Cerner as it is a well-financed compounder, having compounded book value at an average rate of 16% over the past 10 years. Delays in customer adoption of healthcare Information Technology (IT) systems as regulatory mandates have lengthened, exacerbated by concerns about potential changes to the ACA and the impact on healthcare IT spend, have negatively pressured Cerner's common stock price down from over $67 to our initial purchase cost of approximately $48, giving us an opportunity to acquire shares of Cerner common stock at an attractive valuation.

Healthcare IT has been in the sweet spot of spending for hospitals as regulatory reform and increasingly complex regulatory requirements have driven a greater need for IT solutions. The ACA and Health Information Technology Economic and Clinical Health Act (HITECH) were established to transition the U.S. healthcare system from fee-for-service towards value-based outcomes, i.e., incentivizing hospitals and providers for increasing quality of care and patient outcomes rather than the volume of procedures performed. As part of this initiative, electronic health records systems were required and analytics and data collection to monitor outcomes is increasing. Cerner is one of the market leaders in these systems. Similar to other IT companies, services and software for the installed base of systems generates high-margin recurring revenue. Further, many legacy systems are in need of upgrades to enable them to meet the new regulatory requirements. Given its market leading position, Cerner has been gaining share and is well-positioned to continue to take share. In addition, there has been consolidation within the industry, including some vendors discontinuing products.

While uncertainty remains regarding the ultimate resolution of the ACA, we believe the benefit of increased efficiencies that enhanced IT systems provide, along with increasing use cases, e.g., population health, will continue to bode well for Cerner's business, enabling the company to grow and compound value over the longer-term.

From Third Avenue Management (Trades, Portfolio)'s fourth calendar quarter 2016 shareholder letter.

Check out Third Avenue Management,Martin Whitman latest stock trades

Top Ranked Articles about Cerner Corp

Arnold Van Den Berg Invests in 4 New Buys in 4th Quarter Guru purchases shares of Cerner, Occidental Petroleum, Atkore, CVS
Arnold Van Den Berg (Trades, Portfolio), founder of Century Management, added four new positions to the portfolio in the fourth quarter. Read more...
Jeff Auxier Buys Cerner, Yum China and Granite Construction Guru releases quarterly portfolio
Auxier Asset Management President and CEO Jeff Auxier (Trades, Portfolio) gained three new holdings in the final quarter of 2016. They are Cerner Corp. (NASDAQ:CERN), Yum China Holdings Inc. (NYSE:YUMC) and Granite Construction Inc. (NYSE:GVA). Read more...
Third Avenue Management's Top 5 Stock Buys of Q4 Martin Whitman's value-focused firm updates portfolio
The firm founded by legendary investor Martin Whitman (Trades, Portfolio), Third Avenue Management (Trades, Portfolio), selected eight new stocks and its flagship value fund beat the market in the fourth quarter. Read more...
Third Avenue Management Comments on Cerner Guru stock highlight
Cerner (NASDAQ:CERN) is a leading health care information technology company. We have long admired Cerner as it is a well-financed compounder, having compounded book value at an average rate of 16% over the past 10 years. Delays in customer adoption of healthcare Information Technology (IT) systems as regulatory mandates have lengthened, exacerbated by concerns about potential changes to the ACA and the impact on healthcare IT spend, have negatively pressured Cerner's common stock price down from over $67 to our initial purchase cost of approximately $48, giving us an opportunity to acquire shares of Cerner common stock at an attractive valuation. Read more...
CEOs and CFOs Who Quote Buffett and Graham A search project of company officers who have quoted them in shareholder letters
One of my favorite activities is to read letters to shareholders from different companies across different countries. My favorite ones are of course Warren Buffett (Trades, Portfolio)’s letters. Read more...
The Moat Stays Strong, Even if the Listing Is Gone Cerner lost its place on a wide moat list but still retains its moat and has good odds for delivering double-digit growth through the next decade
In mid-September, Cerner Corp. (NASDAQ:CERN) was removed from a prestigious list: The Morningstar Wide Moat Focus IndexSM. Read more...

Ratios

vs
industry
vs
history
PE Ratio 31.40
CERN's PE Ratio is ranked lower than
58% of the 1417 Companies
in the Global Health Information Services industry.

( Industry Median: 26.00 vs. CERN: 31.40 )
Ranked among companies with meaningful PE Ratio only.
CERN' s PE Ratio Range Over the Past 10 Years
Min: 14.92  Med: 36.54 Max: 54.94
Current: 31.4
14.92
54.94
Forward PE Ratio 23.09
CERN's Forward PE Ratio is ranked lower than
52% of the 355 Companies
in the Global Health Information Services industry.

( Industry Median: 21.41 vs. CERN: 23.09 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 31.40
CERN's PE Ratio without NRI is ranked lower than
57% of the 1363 Companies
in the Global Health Information Services industry.

( Industry Median: 26.18 vs. CERN: 31.40 )
Ranked among companies with meaningful PE Ratio without NRI only.
CERN' s PE Ratio without NRI Range Over the Past 10 Years
Min: 14.53  Med: 36.59 Max: 54.94
Current: 31.4
14.53
54.94
Price-to-Owner-Earnings 33.11
CERN's Price-to-Owner-Earnings is ranked lower than
63% of the 742 Companies
in the Global Health Information Services industry.

( Industry Median: 24.46 vs. CERN: 33.11 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CERN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 18.58  Med: 35.87 Max: 104.7
Current: 33.11
18.58
104.7
PB Ratio 5.20
CERN's PB Ratio is ranked lower than
68% of the 1779 Companies
in the Global Health Information Services industry.

( Industry Median: 3.00 vs. CERN: 5.20 )
Ranked among companies with meaningful PB Ratio only.
CERN' s PB Ratio Range Over the Past 10 Years
Min: 2.05  Med: 4.61 Max: 6.92
Current: 5.2
2.05
6.92
PS Ratio 4.15
CERN's PS Ratio is ranked lower than
68% of the 1786 Companies
in the Global Health Information Services industry.

( Industry Median: 2.38 vs. CERN: 4.15 )
Ranked among companies with meaningful PS Ratio only.
CERN' s PS Ratio Range Over the Past 10 Years
Min: 1.67  Med: 4.37 Max: 7.51
Current: 4.15
1.67
7.51
Price-to-Free-Cash-Flow 51.86
CERN's Price-to-Free-Cash-Flow is ranked lower than
77% of the 750 Companies
in the Global Health Information Services industry.

( Industry Median: 26.35 vs. CERN: 51.86 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CERN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 21.57  Med: 48.54 Max: 1841.39
Current: 51.86
21.57
1841.39
Price-to-Operating-Cash-Flow 17.22
CERN's Price-to-Operating-Cash-Flow is ranked higher than
57% of the 923 Companies
in the Global Health Information Services industry.

( Industry Median: 18.94 vs. CERN: 17.22 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CERN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.31  Med: 19.55 Max: 33.32
Current: 17.22
9.31
33.32
EV-to-EBIT 20.86
CERN's EV-to-EBIT is ranked lower than
57% of the 1205 Companies
in the Global Health Information Services industry.

( Industry Median: 17.49 vs. CERN: 20.86 )
Ranked among companies with meaningful EV-to-EBIT only.
CERN' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.1  Med: 22.8 Max: 36.7
Current: 20.86
9.1
36.7
EV-to-EBITDA 13.49
CERN's EV-to-EBITDA is ranked higher than
51% of the 1321 Companies
in the Global Health Information Services industry.

( Industry Median: 13.39 vs. CERN: 13.49 )
Ranked among companies with meaningful EV-to-EBITDA only.
CERN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.7  Med: 14.4 Max: 25.2
Current: 13.49
5.7
25.2
PEG Ratio 1.94
CERN's PEG Ratio is ranked higher than
53% of the 554 Companies
in the Global Health Information Services industry.

( Industry Median: 2.03 vs. CERN: 1.94 )
Ranked among companies with meaningful PEG Ratio only.
CERN' s PEG Ratio Range Over the Past 10 Years
Min: 0.78  Med: 2.21 Max: 3.81
Current: 1.94
0.78
3.81
Shiller PE Ratio 53.78
CERN's Shiller PE Ratio is ranked lower than
63% of the 291 Companies
in the Global Health Information Services industry.

( Industry Median: 39.55 vs. CERN: 53.78 )
Ranked among companies with meaningful Shiller PE Ratio only.
CERN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 34.87  Med: 71.08 Max: 94.06
Current: 53.78
34.87
94.06
Current Ratio 1.92
CERN's Current Ratio is ranked higher than
52% of the 1510 Companies
in the Global Health Information Services industry.

( Industry Median: 1.84 vs. CERN: 1.92 )
Ranked among companies with meaningful Current Ratio only.
CERN' s Current Ratio Range Over the Past 10 Years
Min: 1.92  Med: 2.73 Max: 4.05
Current: 1.92
1.92
4.05
Quick Ratio 1.90
CERN's Quick Ratio is ranked higher than
55% of the 1510 Companies
in the Global Health Information Services industry.

( Industry Median: 1.72 vs. CERN: 1.90 )
Ranked among companies with meaningful Quick Ratio only.
CERN' s Quick Ratio Range Over the Past 10 Years
Min: 1.9  Med: 2.68 Max: 4.01
Current: 1.9
1.9
4.01
Days Inventory 8.39
CERN's Days Inventory is ranked higher than
63% of the 930 Companies
in the Global Health Information Services industry.

( Industry Median: 16.45 vs. CERN: 8.39 )
Ranked among companies with meaningful Days Inventory only.
CERN' s Days Inventory Range Over the Past 10 Years
Min: 7.15  Med: 13.98 Max: 19.85
Current: 8.39
7.15
19.85
Days Sales Outstanding 69.69
CERN's Days Sales Outstanding is ranked lower than
52% of the 1288 Companies
in the Global Health Information Services industry.

( Industry Median: 67.53 vs. CERN: 69.69 )
Ranked among companies with meaningful Days Sales Outstanding only.
CERN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 66.04  Med: 80.17 Max: 102.12
Current: 69.69
66.04
102.12
Days Payable 111.56
CERN's Days Payable is ranked higher than
82% of the 1159 Companies
in the Global Health Information Services industry.

( Industry Median: 40.56 vs. CERN: 111.56 )
Ranked among companies with meaningful Days Payable only.
CERN' s Days Payable Range Over the Past 10 Years
Min: 47.89  Med: 99.82 Max: 115.48
Current: 111.56
47.89
115.48

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -0.90
CERN's 3-Year Average Share Buyback Ratio is ranked higher than
63% of the 1126 Companies
in the Global Health Information Services industry.

( Industry Median: -2.40 vs. CERN: -0.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CERN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.4  Med: -1.5 Max: 0.2
Current: -0.9
-3.4
0.2

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 11.36
CERN's Price-to-Tangible-Book is ranked lower than
76% of the 1462 Companies
in the Global Health Information Services industry.

( Industry Median: 4.40 vs. CERN: 11.36 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CERN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.79  Med: 5.63 Max: 11.36
Current: 11.36
1.79
11.36
Price-to-Intrinsic-Value-Projected-FCF 2.51
CERN's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
60% of the 865 Companies
in the Global Health Information Services industry.

( Industry Median: 1.98 vs. CERN: 2.51 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CERN' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.33  Med: 2.58 Max: 4.7
Current: 2.51
1.33
4.7
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.20
CERN's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
67% of the 117 Companies
in the Global Health Information Services industry.

( Industry Median: 1.44 vs. CERN: 1.20 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 0.95
CERN's Price-to-Median-PS-Value is ranked higher than
71% of the 1553 Companies
in the Global Health Information Services industry.

( Industry Median: 1.15 vs. CERN: 0.95 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CERN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.35  Med: 0.73 Max: 1.54
Current: 0.95
0.35
1.54
Price-to-Peter-Lynch-Fair-Value 1.96
CERN's Price-to-Peter-Lynch-Fair-Value is ranked lower than
55% of the 358 Companies
in the Global Health Information Services industry.

( Industry Median: 1.66 vs. CERN: 1.96 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CERN' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.69  Med: 1.89 Max: 3.42
Current: 1.96
0.69
3.42
Price-to-Graham-Number 3.98
CERN's Price-to-Graham-Number is ranked lower than
70% of the 881 Companies
in the Global Health Information Services industry.

( Industry Median: 2.37 vs. CERN: 3.98 )
Ranked among companies with meaningful Price-to-Graham-Number only.
CERN' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.62  Med: 3.04 Max: 13.67
Current: 3.98
1.62
13.67
Earnings Yield (Greenblatt) % 4.79
CERN's Earnings Yield (Greenblatt) % is ranked higher than
65% of the 1899 Companies
in the Global Health Information Services industry.

( Industry Median: 2.09 vs. CERN: 4.79 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CERN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.7  Med: 4.4 Max: 11
Current: 4.79
2.7
11
Forward Rate of Return (Yacktman) % 17.61
CERN's Forward Rate of Return (Yacktman) % is ranked higher than
70% of the 766 Companies
in the Global Health Information Services industry.

( Industry Median: 10.46 vs. CERN: 17.61 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CERN' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 1.5  Med: 17 Max: 22.8
Current: 17.61
1.5
22.8

More Statistics

Revenue (TTM) (Mil) $4,796
EPS (TTM) $ 1.84
Beta0.94
Short Percentage of Float6.94%
52-Week Range $47.01 - 67.50
Shares Outstanding (Mil)329.72

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 5,232 5,540 6,153
EPS ($) 2.53 2.73 3.05
EPS without NRI ($) 2.53 2.73 3.05
EPS Growth Rate
(Future 3Y To 5Y Estimate)
17.82%
Dividends per Share ($)
» More Articles for CERN

Headlines

Articles On GuruFocus.com
Arnold Van Den Berg Invests in 4 New Buys in 4th Quarter Mar 13 2017 
Jeff Auxier Buys Cerner, Yum China and Granite Construction Mar 01 2017 
Third Avenue Management's Top 5 Stock Buys of Q4 Feb 21 2017 
Third Avenue Management Comments on Cerner Feb 01 2017 
Calendar 4th Quarter Shareholder Letter From Marty Whitman's Third Avenue Value Fund Feb 01 2017 
5 Companies Near 52-Week Lows Jan 04 2017 
4 Stocks Reach Their 3-Year Low Prices Dec 31 2016 
CEOs and CFOs Who Quote Buffett and Graham Dec 12 2016 
5 Companies for Enterprising Investors Near 52-Week Lows Dec 05 2016 
The Moat Stays Strong, Even If the Listing Is Gone Oct 24 2016 

More From Other Websites
Cerner may benefit from VA's health record overhaul Mar 23 2017
Cerner (CERN) Up 2.5% Since Earnings Report: Can It Continue? Mar 23 2017
Maury Regional Health Selects Cerner’s Integrated Health IT System Mar 22 2017
Cerner Corp. :CERN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Mar 17 2017
Cerner: Tech can help reduce uninsured pains from ACA reform Mar 14 2017
Arnold Van Den Berg Invests in 4 New Buys in 4th Quarter Mar 13 2017
Cerner's new campus brings out the bells and whistles Mar 10 2017
Cerner, State and Local Leaders Commemorate Innovations With Ribbon-Cutting Mar 09 2017
Palmetto Health Expands Cerner Health IT System Mar 07 2017
CERNER CORP /MO/ Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... Mar 06 2017
Cerner Announces Appointment of Julie Gerberding to Its Board of Directors Mar 06 2017
Attorney hopes Cerner suits will push tech to change OT approach Mar 06 2017
Tech Mahindra buys American healthcare IT firm Mar 06 2017
Martin Whitman’s Third Avenue Bullish on Regional Banks, Healthcare IT in 2017 Mar 02 2017
Jeff Auxier Buys Cerner, Yum China and Granite Construction Mar 01 2017
Cerner downgraded by Citigroup Feb 24 2017
Third Avenue Management's Top 5 Stock Buys of Q4 Feb 21 2017
Stocks Our Favorite Large-Cap Managers Have Been Buying Feb 20 2017
Cerner IT support: 'We've flipped the model upside-down' Feb 17 2017
Cerner to Highlight Value-Add Delivery Services in Booth 2161 at HIMSS17 Feb 17 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)